1. Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8
   Philippe Bergeron et al, 2016, ACS Medicinal Chemistry Letters CrossRef
2. Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases
   Paul A Clarke et al, 2016, eLife CrossRef
3. Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells
   Michael F. T. Koehler et al, 2016, ACS Medicinal Chemistry Letters CrossRef
4. Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy?
   Stephen Philip et al, 2018, Journal of Medicinal Chemistry CrossRef
5. CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells
   Akito Nakamura et al, 2018, Oncotarget CrossRef
6. Retroviral Cyclin Controls Cyclin-Dependent Kinase 8-Mediated Transcription Elongation and Reinitiation
   Claire H. Birkenheuer et al, 2015, Journal of Virology CrossRef
7. CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene
   Zainab A. Bazzi et al, 2021, Frontiers in Oncology CrossRef
8. Insights into the regulatory role and clinical relevance of mediator subunit, MED12, in human diseases
   Srishti Srivastava et al, 2021, Journal of Cellular Physiology CrossRef